Isbn: 9780896032095 - serological cancer markers (contemporary biomedicine, band 11) (7 Ergebnisse)

Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Hardcover. 536 p. Good condition. Reading pages are clean and without markings. Out-of-print library copy with appropriate markings. Book shows slight signs of storage or use. With soiled dust jacket. Dust jacket with marginal tears. Dust jacket slightly stained. Spine edge slightly bumped. Otherwise a good copy. 9780896032095 Sprache: Englisch Gewicht in Gramm: 1102. …

Zustand: New. In English.

Gebunden. Zustand: New.

Zustand: New. Provides information on the clinical use of cancer markers - focusing on those detected in the serum - for the diagnosis of cancer, as well as for monitoring various aspects of patients' progress and prognosis. This title takes into account the growth in applications of these cancer marker assays. Editor(s): Sell, Stewart. Series: Contemporary Biomedicine. Num Pages: 536 pages, biography. BIC Classification: MJA; MJCJ; MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 30. Weight in Grams: 951. . 1992. Hardback. . . . . Books ship from the US and Ireland.…

Buch. Zustand: Neu. Neuware - The purpose of this book-the fourth volume of a series on Can cer Markers-is intended to provide an updated 'status report' on today's use of cancer markers in the diagnosis and monitoring of can cer, with an emphasis on cancer markers detected in the serum. It has been 7 years since the publication of the last volume in this series. The 1980, 1982, and 1985 volumes covered the development of cancer markers, not only in their roles of unraveling the basic biology of can cer, but also as increasingly important players in the management of patients with cancer. During the last 7 years we have seen the applica tion of a number of markers identified by monoclonal antibodies, as well as the beginnings of the use of genetic markers defined by mo lecular probes. Measurements of oncogenes in tissues or cells prom ise many applications for the future, but as yet, these genes have not shown to be useful as serum markers of cancer. The commercial interest in serum markers for cancer, particu larly for the diagnosis and monitoring of tumor patients, is indicated in Chapter 24 by Owen, where the total worldwide market for cancer markers is projected to increase from $148 million in 1988 to $232 million in 1993. The degree of research interest in cancer markers is reflected in the fact that in 1988 a separate category for tumor mark ers was added to Index Medicus.…

Zustand: gut. 1992. Serological Cancer Markers ; Contemporary Biomedicine In englischer Sprache. pages.